Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution-Reference-Cited by-同舟云学术

Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution

Published:2018-06 Issue:1 Volume:544 Page:242-253
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Davis Mark T.,Potter Catherine B.,Walker Gavin M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus® processed by hot melt extrusion;Albadarin;Int. J. Pharm.,2017

2. Modern Pharmaceutics, Fourth Edition, Drugs and the Pharmaceutical Sciences;Banker,2002

3. Beyerinck, R.A., Ray, R.J., Dobry, D.E., Settell, D.M., 2010. Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles.

4. Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?;Brouwers;J. Pharm. Sci.,2009

5. A rheological model for the flowability of aerated fine powders;Bruni;Chem. Eng. Sci.,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Polyamorphism on the Morphology, Dissolution, and Stability of Olaparib;Crystal Growth & Design;2024-06-10

2. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.;Pharmaceutical Development and Technology;2024-01-25

3. Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions;Molecular Pharmaceutics;2023-09-12

4. Development, recent advances, and updates in binary, ternary co-amorphous systems, and ternary solid dispersions;Journal of Drug Delivery Science and Technology;2023-09

5. Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer;Pharmaceutical Development and Technology;2023-07-15